MYC (MYC proto-oncogene, bHLH transcription factor), LNX1, YBX1, FN1, TK1 and ANLN (anillin actin binding protein) are likely to provide new potential biomarkers for clinical practice or treatment of T1DM with further research. The gene discussed is MYC; the disease is type 1 diabetes mellitus.